Harold Bernstein sold $426K of Maze Therapeutics, Inc. (MAZE) stock

Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 16,141 shares of MAZE stock worth $426K, per an SEC Form 4 filed Sep 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 1, 2026, 2 days before it was made public.

MAZE has moved +7.0% since the trade date, from $26.53 to $28.38 (Sep 22, 2026 close).